Skip to content

Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy

Document Type
Publications · Review Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q1Scopus Q1
Journal
CARCINOGENESIS39(12) · pp.1419 · 2018
Citation
Web of Science 92Scopus 98
FWCI (Scopus)
1.13
JCR IF
JCR 2017 5.072
ISSN
0143-3334

Authors

  1. Badrinath, NarayanasamyFirst authorBiomedical Sciences, School of Medicine, Pusan National University, Yangsan, South Korea
  2. Yoo, So YoungCorresponding authorBIO-IT Foundry Technology Institute, Pusan National University, Busan, South Korea

Abstract

Mitochondria play pivotal roles in most eukaryotic cells, ranging from energy production to regulation of apoptosis. As sites of cellular respiration, mitochondria experience accumulation of reactive oxygen species (ROS) due to damage in electron transport chain carriers. Mutations in mitochondrial DNA (mtDNA) as well as nuclear DNA are reported in various cancers. Mitochondria have a dual role in cancer: the development of tumors due to mutations in mitochondrial genome and the generation of ROS. Impairment in the mitochondria-regulated apoptosis pathway accelerates tumorigenesis. Numerous strategies targeting mitochondria have been developed to induce the mitochondrial (i.e. intrinsic) apoptosis pathway in cancer cells. This review elaborates the roles of mitochondria in cancer with respect to mutations and apoptosis and discusses mitochondria-targeting strategies as cancer therapies to enhance the killing of cancer cells.

Keywords

CELL-DEATH PATHWAYDNA MUTATIONSCOMPLEX-IMICROSATELLITE INSTABILITYCOLORECTAL CARCINOMASHEXOKINASE-IICYTOCHROME-CGENOMIC INSTABILITYAEROBIC GLYCOLYSISPYLORI INFECTION

Identifiers

Scopus EID
2-s2.0-85059498600
WoS UID
000456035400001